Skip to main content
Equibles

MORGAN STANLEY

Position in CELZ — Creative Medical Technology Holdings, Inc.

CIK 895421 NEW YORK, NY
Back to CELZ Full portfolio

Position in CELZ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$745
-$355 QoQ
Shares Held
514
-3.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 15 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CELZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. CELZ ranks #474 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CELZ

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $745 514
2026-03-31 $1,100 534
2025-12-31 $66 34
2025-09-30 $113 34
2025-06-30 $53 20
2025-03-31 $43 20
2024-12-31 $46 20
2024-09-30 $61 20
2024-06-30 $77 20
2024-03-31 $104 20
2023-12-31 $92 20
2023-09-30 $98 20
2023-06-30 $92 20
2023-03-31 $100 200
2022-12-31 $76 200